IP Library › Assignment 075393/0698
Patent Assignment
Reel/Frame 075393/0698

Security Interest

Recorded: 2026-07-24 Pages: 6
Assignors
ALBION LABORATORIES, INC.
Executed: 2026-07-24
BALCHEM CORPORATION
Executed: 2026-07-24
Assignee
JPMORGAN CHASE BANK, N.A.
10 SOUTH DEARBORN, FLOOR L2, SUITE IL1-1145, CHICAGO, ILLINOIS, 60603-2300
Covered Properties (11)
Transgenic Plants Expressing Cobalamin Binding Proteins
Patent: 9,751,918 →
Application: 12/357,622 →
Publication: US US20100184642A1
Reactive Granulation of Calcium Citrate Malate, Dicalcium Malate, and Dimagnesium Malate
Application: 18/195,239 →
Publication: US US20230357280A1
Methods of Increasing Magnesium Bioavailability and Absorption
Application: 18/373,611 →
Publication: US US20240016780A1
Intra-Dosage Form Coatings and Applications Thereof
Application: 18/845,997 →
Publication: US US20250073175A1
Reactive Granulation of Calcium Citrate Malate, Dicalcium Malate, and Dimagnesium Malate
Application: 18/863,875 →
Publication: US US20260183256A1
Use of Methylsulfonylmethane (Msm) to Modulate Microbial Activity
Patent: 8,841,100 →
Application: 13/029,001 →
Publication: US US20110136210A1
Methylsulfonylmethane (Msm) for Treatment of Drug Resistant Microorganisms
Patent: 8,217,085 →
Application: 13/399,921 →
Publication: US US20120149672A1
Methods of Sensitizing Drug Resistant Microorganisms Using Methylsulfonylmethane (Msm)
Patent: 8,546,373 →
Application: 13/458,907 →
Publication: US US20120264726A1
Use of Methylsulfonylmethane (Msm) to Modulate Microbial Activity
Patent: 9,487,749 →
Application: 14/458,148 →
Publication: US US20140349375A1
Compositions and Methods for Increasing Dha Availability
Compositions and Methods for Improving Brain Function
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement Sep 14, 2010
From: DRUGTECH CORPORATION
To: U.S. HEALTHCARE I, L.L.C.
Reel/Frame 024982/0344 →
Patent Security Agreement Nov 20, 2010
From: DRUGTECH CORPORATION
To: U.S. HEALTHCARE I, LLC
Reel/Frame 025385/0498 →
Lien Feb 22, 2011
From: U.S. HEALTHCARE I, L.L.C.
To: DRUGTECH CORPORATION
Reel/Frame 025851/0819 →
Release of Security Interest Feb 22, 2011
From: U.S. HEALTHCARE I, L.L.C.
To: DRUGTECH CORPORATION
Reel/Frame 025843/0887 →
Assignment of Assignor's Interest Feb 24, 2011
From: DRUGTECH CORPORATION
To: BENE CONSULTING L.C.
Reel/Frame 025855/0958 →
Assignment of Assignor's Interest Feb 24, 2011
From: DRUGTECH CORPORATION
To: BENE CONSULTING L.C.
Reel/Frame 025855/0669 →
Corrective Assignment to Correct the Nature of Conveyence Previously Recorded on Reel 025851 Frame 0819. Assignor(S) Hereby Confirms the Correct Nature of Conveyence Is: Release by Secured Party. Mar 16, 2011
From: U.S. HEALTHCARE I, L.L.C.
To: DRUGTECH CORPORATION
Reel/Frame 025959/0448 →
Release of Security Interest Mar 18, 2011
From: U.S. HEALTHCARE I, LLC (AS ADMINISTRATIVE AND COLLATERAL AGENT)
To: DRUGTECH CORPORATION
Reel/Frame 025981/0934 →
Assignment of Assignor's Interest Mar 18, 2011
From: BENJAMIN, RODNEY; VARELMAN, JEFFREY; KELLER, ANTHONY L.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 025983/0906 →
Release of Security Interest Mar 18, 2011
From: U.S. HEALTHCARE, LLC (AS ADMINISTRATIVE AND COLLATERAL AGENT)
To: DRUGTECH CORPORATION
Reel/Frame 025980/0024 →
Assignment of Assignor's Interest Apr 17, 2012
From: BENJAMIN, RODNEY; VARELMAN, JEFFREY; KELLER, ANTHONY L.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 028058/0806 →
Assignment of Assignor's Interest May 30, 2012
From: BENE CONSULTING, L.C.
To: ATERES YESHUA, LLC
Reel/Frame 028290/0659 →
Assignment of Assignor's Interest Jun 1, 2012
From: BENE CONSULTING, L.C.; ATERES YESHUA, LLC
To: XERAGENX LLC
Reel/Frame 028315/0339 →
Assignment of Assignor's Interest Nov 16, 2012
From: CARDINAL ASSOCIATES, INC.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 029315/0549 →
Assignment of Assignor's Interest Nov 16, 2012
From: ABELA PHARMACEUTICALS, INC.
To: CARDINAL ASSOCIATES, INC.
Reel/Frame 029315/0495 →
Assignment of Assignor's Interest Jul 2, 2013
From: TANDEM-ABELA DEVELOPMENT GROUP, LLC
To: ABELA PHARMACEUTICALS, INC.
Reel/Frame 030746/0397 →
Assignment of Assignor's Interest Jul 2, 2013
From: COZEAN, COLETTE; BENJAMIN, RODNEY; KELLER, ANTHONY; VARELMAN, JEFFREY
To: TANDEM-ABELA DEVELOPMENT GROUP, LLC
Reel/Frame 030731/0650 →
Assignment of Assignor's Interest Aug 14, 2014
From: BENJAMIN, RODNEY; VARELMAN, JEFFREY; KELLER, ANTHONY L.
To: BIOGENIC INNOVATIONS, LLC
Reel/Frame 033540/0093 →
Assignment of Assignor's Interest Feb 19, 2019
From: BENE CONSULTING, LLC; ATERES YESHUA, LLC
To: XERAGENX, LLC
Reel/Frame 048366/0382 →
Security Interest Apr 25, 2019
From: XERAGENX, LLC
To: BALCHEM CORPORATION
Reel/Frame 048998/0590 →
Assignment of Assignor's Interest May 15, 2023
From: GONZALEZ, REN A.; JENNESS, TOD
To: BALCHEM CORPORATION
Reel/Frame 063645/0139 →
Asset Assignment Agreement Jun 11, 2024
From: BIOGENIC INNOVATIONS, LLC
To: CARDINAL ASSOCIATES, INC.
Reel/Frame 067698/0938 →
Merger Jun 11, 2024
From: CARDINAL ASSOCIATES, INC.
To: ALBION LABORATORIES, INC.
Reel/Frame 067695/0404 →
Assignment of Assignor's Interest Nov 7, 2024
From: GONZALEZ, REN A.; JENNESS, TOD
To: BALCHEM CORPORATION
Reel/Frame 069187/0233 →
Assignment of Assignor's Interest Nov 12, 2024
From: MORGAN, SHANE CHRISTOPHER; GONZALEZ, REN A
To: BALCHEM CORPORATION
Reel/Frame 069224/0817 →